• Home>
  • Stocks>
  • Healthcare Global Enterprises Ltd Share Price
Healthcare Global Enterprises Ltd share price logo

Healthcare Global Enterprises Ltd Share Price

(HCG)

₹527.952.61%

as on 12:30PM, 01 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Healthcare Global Enterprises Ltd Performance

  • Day's Low

    Day's High

    ₹527.05
    Day's Price Range
    ₹547.95
  • 52 Week's Low

    52 Week's High

    ₹326
    52-Week Price Range
    ₹567.7
1 Month Return+ 10.66 %
3 Month Return+ 11.77 %
1 Year Return+ 60.91 %
Previous Close₹542.10
Open₹527.90
Volume1.21L
Upper Circuit₹650.50
Lower Circuit₹433.70
Market Cap₹7,557.71Cr

Healthcare Global Enterprises Ltd Fundamentals

P/E Ratio

129.38

PEG Ratio

77.94

Market Cap

₹7,557.71 Cr

P/B Ratio

3.96

EPS

2.97

Dividend Yield

0

Sector

Healthcare

ROE

3.22

Healthcare Global Enterprises Ltd Analyst Rating

based on 8 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 8 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹526.25

Source: S&P Global Market Intelligence

Healthcare Global Enterprises Ltd Share analysis

Healthcare Global Enterprises Ltd price forecast by 8 analysts

Downside of-2.92%

High

₹621

Target

₹526.25

Low

₹342

Healthcare Global Enterprises Ltd target price ₹526.25, a slight downside of -2.92% compared to current price of ₹527.95. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Key events for Healthcare Global Enterprises Ltd

  • HCG Stock Poised for Breakout - 24 Mar, 2025

    Healthcare Global Enterprises Ltd (HCG) is on the verge of breaking out from consolidation, trading near its 52-week high. Key indicators like RSI and MACD suggest a sustainable uptrend, with the stock forming higher tops and bottoms on the daily chart. Target price is set at Rs. 578.625 with a stop-loss at Rs. 481.
  • Axis Securities Recommends Buy on Healthcare Global - 21 Mar, 2025

    Axis Securities has issued a buy recommendation for Healthcare Global Enterprises with a target price of Rs 575. The company is expanding its operations, planning to add 900 beds, and is expected to improve margins significantly. Despite a slight decline in recent total income, the company is outpacing the growing cancer industry. Key risks include project slowdowns and regulatory changes.
  • Healthcare Global Reports Strong Financial Growth - 20 Mar, 2025

    Healthcare Global Enterprises Ltd reported a significant increase in net sales, up 18.88% year-on-year to Rs 558.57 crore for December 2024. Net profit rose 22.46% to Rs 6.98 crore, while EBITDA increased by 9.84%. The company's EPS also improved to Rs 0.50. Shares closed at Rs 500.30, reflecting a 20.26% return over the last six months and 50.15% over the past year.
  • KKR and KIA EBT Seek Stake in Healthcare Global Enterprises - 12 Mar, 2025

    KKR-backed Hector Asia and KIA EBT have applied for CCI approval to acquire a controlling stake in Healthcare Global Enterprises Limited, potentially increasing their ownership to 77%. This acquisition could significantly impact the Indian healthcare sector.
  • KKR's Stake Expected to Boost HCG Growth - 28 Feb, 2025

    KKR's acquisition of a 51% stake in Healthcare Global Enterprises is anticipated to improve operational efficiency and drive growth through bed expansion and margin scaling. Analysts project a 23% EBITDA CAGR from FY25-27E, with a revised target price of Rs 555/share.

Insights on Healthcare Global Enterprises Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, HCG stock has moved up by 11.8%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 12.83% to 13.06% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.94% to 10.04% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 212.7% return, outperforming this stock by 115.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.23% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 62.8% return, outperforming this stock by 1.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 4.29% to 2.77% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 564.67 Cr → 564.11 Cr (in ₹), with an average decrease of 0.1% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 17.99 Cr → 6.98 Cr (in ₹), with an average decrease of 61.2% per quarter

Healthcare Global Enterprises Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹468.95Cr (-)₹493.25Cr (↑5.18%)₹524.69Cr (↑6.37%)₹552.47Cr (↑5.29%)₹557.55Cr (↑0.92%)
Net Income₹3.43Cr (-)₹23.46Cr (↑583.97%)₹13.63Cr (↓41.90%)₹20.68Cr (↑51.72%)₹7.75Cr (↓62.52%)
Net Profit Margin0.73% (-)4.76% (↑552.05%)2.60% (↓45.38%)3.74% (↑43.85%)1.39% (↓62.83%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,655.87Cr (-)₹1,722.91Cr (↑4.05%)₹1,815.94Cr (↑5.40%)₹2,297.46Cr (↑26.52%)
Total Liabilities₹732.08Cr (-)₹625.22Cr (↓14.60%)₹670.81Cr (↑7.29%)₹1,108.87Cr (↑65.30%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹86.34Cr (-)₹70.89Cr (↓17.89%)₹124.40Cr (↑75.48%)₹130.40Cr (↑4.82%)₹194.71Cr (↑49.32%)

Healthcare Global Enterprises Ltd Index Inclusions

BSE Healthcare

₹40,963.95

-1.1 (-457.55%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹46,632.67

-0.01 (-5.46%)

Healthcare Global Enterprises Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
71.23%
-0.01
Foreign Institutions
2.77%
-35.40
Mutual Funds
10.04%
12.23
Retail Investors
13.06%
1.82
Others
2.9%
7.40

Healthcare Global Enterprises Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)-14.14-17.642.81.272.97
Details202220232024
Return On Equity %1.193.073.22
Details20202021202220232024
Return On Assets %-5.8-11.683.121.622.1
Details20202021202220232024
Book Value Per Share (₹)42.9952.1162.6161.8659.28

Healthcare Global Enterprises Ltd Valuation

Healthcare Global Enterprises Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-514.24x)

November 27, 2018

Industry (98.78x)

March 28, 2025

Today (129.38x)

March 28, 2025

Highest (201.31x)

July 2, 2018

LowHigh

Healthcare Global Enterprises Ltd Earnings and Dividends

  • Healthcare Global Enterprises Ltd Earnings Results

    Healthcare Global Enterprises Ltd’s net profit jumped 22.46% since last year same period to ₹6.98Cr in the Q3 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated -61.2% fall in its net profits since last 3-months.

    Read More about Earnings Results

Healthcare Global Enterprises Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Healthcare Global Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.

Healthcare Global Enterprises Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹7,557.71 Cr127.41%0.70₹41 Cr₹1,907 Cr
NA₹109.60 Cr80.59%0.59₹10 Cr₹199 Cr
NA₹139.31 Cr40.35%0.51NANA
NA₹23.00 Cr-17.19%0.58NANA
BUY₹25,592.89 Cr44.16%0.58₹336 Cr₹2,498 Cr

About Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Ltd (HCG) is a leading provider of specialty healthcare services in India, focused on cancer and fertility. With 18 comprehensive cancer centres and 7 fertility centres across India, HCG operates two multispeciality hospitals in Ahmedabad and Bhavnagar with 118 and 39 operational beds respectively, and its key specialties include cardiology, neurology, orthopaedics, and urology. It also provides clinical reference laboratory services in India under the Triesta brand specialising in oncology, and research and development services to pharmaceutical and biotechnology companies.

Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.

Revenue: ₹557.55Cr as on December 2024 (Q4 24)
Net Profit: ₹7.75Cr as on December 2024 (Q4 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
OrganisationHealthcare Global Enterprises Ltd
HeadquartersBengaluru
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Healthcare Global Enterprises Ltd

What is Healthcare Global Enterprises Ltd price today?

Healthcare Global Enterprises Ltd share price today stands at ₹527.95, Open: ₹527.9, Previous Close: ₹542.1, High: ₹547.95, Low: ₹527.05, 52 Week High: ₹567.7, 52 Week Low: ₹326.

How to Buy Healthcare Global Enterprises Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Healthcare Global Enterprises Ltd shares

What are today's traded volumes of Healthcare Global Enterprises Ltd?

Today's traded volume of Healthcare Global Enterprises Ltd(HCG) is 1.21L.

What is today's market capitalisation of Healthcare Global Enterprises Ltd?

Today's market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹7557.71Cr.

What is the 52 Week High and Low Range of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd (HCG)
Price
52 Week High
₹567.7
52 Week Low
₹326

How much percentage Healthcare Global Enterprises Ltd is down from its 52 Week High?

Healthcare Global Enterprises Ltd (HCG) share price is ₹527.95. It is down -7.00% from its 52 Week High price of ₹567.7

How much percentage Healthcare Global Enterprises Ltd is up from its 52 Week low?

Healthcare Global Enterprises Ltd (HCG) share price is ₹527.95. It is up 61.95% from its 52 Week Low price of ₹326